Literature DB >> 16761637

Long-term results of hang-back lateral rectus recession.

Alexandre C Rodrigues1, Leonard B Nelson.   

Abstract

PURPOSE: To report long-term results of the hang-back technique for lateral rectus muscle recession. PATIENTS AND METHODS: The medical records of 79 consecutive patients who underwent unilateral or bilateral hang-back lateral rectus recession were reviewed. The amount of surgery performed was based on the distance exotropic deviation. Surgical outcomes were analyzed for all patients included in the study.
RESULTS: Forty-two patients met the inclusion criteria. Four of the patients were not orthophoric: three had recurrent exotropia and one had a consecutive esotropia. The average interval prior to the second procedure was 9 months.
CONCLUSION: The hang-back technique is a safe and effective alternative to conventional lateral rectus recession.

Entities:  

Mesh:

Year:  2006        PMID: 16761637     DOI: 10.3928/01913913-20060301-04

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  4 in total

1.  Stability of Y-splitting procedure combined with hang-back recession of the rectus muscle in rabbit eyes.

Authors:  Soh-Eun Ahn; Ji-Yun Han; Seung-Hyun Kim; Yoonae A Cho; Young-Woo Suh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-01       Impact factor: 3.117

2.  [Comparison of hang-back recession and conventional recession for correction of exotropia].

Authors:  S Schönfeld; S Heede; D J Salchow
Journal:  Ophthalmologe       Date:  2016-05       Impact factor: 1.059

3.  The effect of botulinum toxin injection on the hang-back recession of rectus muscles.

Authors:  Young-Woo Suh; Jin-Hwan Park; Yoonae Ann Cho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-01-21       Impact factor: 3.117

4.  Effect of fibrin glue as an adjuvant to hang-back surgery.

Authors:  Jihyun Park; Jung Jin Lee; Eun Hye Lim; Joon H Lee; Kyung Hyun Jin; Ungsoo Samuel Kim
Journal:  BMC Ophthalmol       Date:  2012-06-07       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.